Assembly Biosciences, Inc. Cost of Reimbursable Expense (Deprecated 2018-01-31)
Assembly Biosciences, Inc. (ASMB) reported Cost of Reimbursable Expense (Deprecated 2018-01-31) of $200.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-07.
Discontinued › Expense Statement
us-gaap:CostOfReimbursableExpense · last filed 2018-05-07
- Assembly Biosciences, Inc. cost of reimbursable expense (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $200.00K.
- Assembly Biosciences, Inc. cost of reimbursable expense (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.10M.
- Assembly Biosciences, Inc. cost of reimbursable expense (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.40M.
- Assembly Biosciences, Inc. cost of reimbursable expense (deprecated 2018-01-31) for fiscal 2017 was $4.60M.
| Period end | Cost of Reimbursable Expense (Deprecated 2018-01-31) 3 month | Cost of Reimbursable Expense (Deprecated 2018-01-31) 6 month | Cost of Reimbursable Expense (Deprecated 2018-01-31) 9 month | Cost of Reimbursable Expense (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $200.00K 10-Q · filed 2018-05-07 | $2.30M derived: sum of 2 quarters · filed 2018-05-07 | $3.70M derived: sum of 3 quarters · filed 2018-05-07 | |
| 2017-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $3.50M derived: sum of 2 quarters · filed 2018-03-08 | $4.60M 10-K · filed 2018-03-08 | |
| 2017-09-30 | $1.40M 10-Q · filed 2017-11-01 | $2.50M 10-Q · filed 2017-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |